Oncology

CE/CME ACTIVITIES for oncology advanced practice providers

To receive credit, please review the activity content and click on the link to the post-test provided below for each activity.

e-Newsletter Series

Extending Survival and Maximizing Quality of Life in Hormone Receptor–Positive Advanced Breast Cancer

Program Number: OPCE89816-7A

Release Date: July 31, 2017

Expiration Date: July 30, 2018

Credit Hours: 1.00

Pharmacology Hours for NPs: 1.00

e-Newsletter Series

Upfront Treatment of Non–Small-Cell Lung Cancer in Patients Lacking an Identifiable Activating Mutation  

Program Number: OPCE89816-7B

Release Date: July 31, 2017

Expiration Date: July 30, 2018

Credit Hours: 1.00

Pharmacology Hours for NPs: 1.00

e-Newsletter Series

Best Practices for the Management of Metastatic Prostate Cancer Across the Disease Continuum  

Program Number: OPCE89816-7C

Release Date: July 31, 2017

Expiration Date: July 30, 2018

Credit Hours: 1.00

Pharmacology Hours for NPs: 1.00

e-Newsletter Series

Novel Agents in Relapsed/Refractory Multiple Myeloma: Individualizing Treatment to Maximize Disease Control

Program Number: OPCE89816-7D

Release Date: July 31, 2017

Expiration Date: July 30, 2018

Credit Hours: 1.00

Pharmacology Hours for NPs: 1.00

e-Newsletter Series

Chemotherapy-Induced Nausea and Vomiting: Strategies for Achieving Optimal Control

Program Number: OPCE89816-7E

Release Date: July 31, 2017

Expiration Date: July 30, 2018

Credit Hours: 1.00

Pharmacology Hours for NPs: 1.00

e-Newsletter

Evolving Approaches to Improve Outcomes in Hormone Receptor–Positive Advanced Breast Cancer

Program Number: LPCE92117

Release Date: June 9, 2017

Expiration Date: June 9, 2018

Credit Hours: 1.00

e-Case

First-Line Treatment of Non–Small-Cell Lung Cancer When There Is No Actionable Molecular Biomarker  

Program Number: LPCE92017

Release Date: May 5, 2017

Expiration Date: May 5, 2018

Credit Hours: 0.50

Pharmacology Hours for NPs: 0.25

Disclaimer: The materials presented here do not necessarily reflect the views of Continuing Education Alliance, Practicing Clinicians Exchange, or companies that provide educational support for programming on practicingclinicians.com. These activities may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. Readers should verify all information and data before treating patients or implementing any therapies described in these educational activities. © 2017 Continuing Education Alliance and Practicing Clinicians Exchange. All Rights Reserved. Terms and Conditions.